Intrinsic Edge Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24,591
Closed -$2.79M 122
2024
Q2
$2.79M Sell
24,591
-16,506
-40% -$2.09M 0.25% 110
2024
Q1
$5.7M Buy
+41,097
New +$5.17M 0.45% 75
2023
Q4
Sell
-60,854
Closed -$5.68M 129
2023
Q3
$5.68M Buy
60,854
+30,000
+97% +$3.38M 0.64% 61
2023
Q2
$3.97M Hold
30,854
0.28% 107
2023
Q1
$3.58M Sell
30,854
-68,167
-69% -$7.63M 0.36% 96
2022
Q4
$11.2M Sell
99,021
-19,219
-16% -$2.11M 1.12% 29
2022
Q3
$9.52M Buy
118,240
+60,000
+103% +$5.08M 1.04% 36
2022
Q2
$4.34M Hold
58,240
0.34% 90
2022
Q1
$7.45M Hold
58,240
0.57% 69
2021
Q4
$7.82M Sell
58,240
-6,940
-11% -$997K 0.5% 74
2021
Q3
$8.91M Sell
65,180
-70,360
-52% -$8.87M 0.62% 60
2021
Q2
$14.5M Buy
135,540
+74,428
+122% +$7.15M 0.85% 25
2021
Q1
$5.49M Sell
61,112
-100,184
-62% -$9.4M 0.37% 98
2020
Q4
$14.9M Buy
161,296
+91,540
+131% +$8.17M 1.1% 19
2020
Q3
$7.19M Buy
69,756
+30,816
+79% +$3.22M 0.49% 71
2020
Q2
$3.95M Sell
38,940
-77,040
-66% -$6.89M 0.36% 105
2020
Q1
$7.81M Buy
+115,980
New +$7.22M 1.03% 30

Other funds holding DXCM

Intrinsic Edge Capital Management's DXCM Position: Q3 2024 in Review

Intrinsic Edge Capital Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 24,591 shares — an estimated $2.79M sold.

Intrinsic Edge Capital Management first reported a position in DXCM in Q1 2020 and held it in 17 quarters. The position peaked at $14.9M in Q4 2020. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Intrinsic Edge Capital Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 24,591 DexCom shares in Q3 2024, an estimated $2.79M.
  • Intrinsic Edge Capital Management first reported a position in DexCom in Q1 2020 and held it in 17 quarters.
  • Intrinsic Edge Capital Management's DexCom position peaked at $14.9M in Q4 2020.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Intrinsic Edge Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.